gage_trump

Trump to announce leaders of the US project to develop a coronavirus vaccine

May 14, 2020
Business Services COVID-19, Trump, Vaccine, coronavirus

President Donald Trump is set to announce that Moncef Slaoui, the former head of GlaxoSmithKline’s vaccine division, and Gustave Perna, …

blood_test

Public Health England approves COVID-19 antibodies test from Roche

May 14, 2020
Business Services COVID-19, coronavirus

Public Health England (PHE) have approved Roche’s antibody test to help determine how much of the population has been infected …

fda

FDA grants Fast Track designation for Moderna’s coronavirus vaccine candidate

May 13, 2020
Research and Development COVID-19, coronavirs

The FDA has granted Fast Track designation for Moderna Inc’s mRNA vaccine candidate against the coronavirus. The regulatory body had …

researcherssss

AMAG Pharmaceuticals to cut 30% of staff as part of restructure

May 13, 2020
Research and Development COVID-19, coronavirus

AMAG Pharmaceuticals announced that it will cut 30% of its staff, or 140 jobs, as part of a companywide restructuring. …

generics

Gilead signs deal with generic drugmakers to expand global supply of remdesivir

May 13, 2020
Research and Development COVID-19, coronavirus, remdesivir

Gilead Sciences has signed an exclusive licensing agreement with five generics drug companies in India and Pakistan to supply them …

coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 13, 2020
Research and Development COVID-19, coronavirus

Developments in treatments for COVID-19 continue to dominate the news as the latest in hydroxychloroquine trials shows it does not …

trialsssssss

Researchers in Denmark testing if senicapoc drug can reduce lung damage in COVID-19 patients

May 13, 2020
Research and Development COVID-19, Sars, coronavirus

Scientists are studying if senicapoc, a treatment for sickle cell anemia, can be repurposed to mitigate damage to a COVID-19 …

japan_mhlw

Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19

May 12, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir

Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …

antibody

FDA grants Abbott Emergency Use Authorization for another COVID-19 antibody test

May 12, 2020
Manufacturing and Production COVID, COVID-19, coronavirus, pandemic, tests

The FDA has given Emergency Use Authorisation for another COVID-19 diagnostics test for antibodies from Abbott Laboratories. With this approval, …

wuhan_citiy

Wuhan plans to test all 11 million residents for COVID-19 after 6 new cases are recorded

May 12, 2020
Manufacturing and Production COVID-19, coronavirus, pandemic

The Chinese city of Wuhan, where the coronavirus originated, plans to test all of its residents after 6 new cases …

clinical_study

Genfit’s NASH drug fails Phase 3 clinical trial

May 12, 2020
Manufacturing and Production FDA, nash

The Phase 3 trial for Genfit’s drug elafibranor has failed to improve outcomes for patients with the fatty liver disease …

fda

FDA provides new guidelines to accelerate the development of COVID-19 treatments

May 12, 2020
Manufacturing and Production COVID-19, FDA, coronavirus, pandemic

The FDA has provided new guidelines to researchers studying potential COVID-19 treatments to help speed up the process of their …

takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous Entyvio approved in Europe for maintenance of moderate to severe Crohn’s and ulcerative colitis

May 11, 2020
Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, ulcerative colitis

The European Commission has awarded marketing approval to Takeda’s subcutaneous formulation of its gut-selective biologic therapy Entyvio (vedolizumab) as a …

nhs_doctors

Latest large hydroxychloroquine study suggests it does not help treat COVID-19

May 11, 2020
Sales and Marketing COVID-91, coronavirus, hydroxychloroquine

The results of another study into the use of hydroxychloroquine in COVID-19 patients has cast further doubts on its effectiveness …

fda2outsideweb

Lynparza combo authorised in US for first-line maintenance of HRD-positive advanced ovarian cancer

May 11, 2020
Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer

Lynparza (olaparib), developed by AstraZeneca and MSD, has secured FDA approval when paired with bevacizumab as a first-line maintenance treatment …

fda

Eli Lilly’s Retevmo approved by FDA to treat lung and thyroid cancers

May 11, 2020
Sales and Marketing COVID-19, coronavirus

The FDA has announced that Retevmo (selpercatinib) has been approved to treat both non-small-cell lung cancer (NSCLC) and medullary thyroid …

trial

NIAID announces the launch of second remdesivir trial for COVID-19 patients

May 11, 2020
Sales and Marketing COVID-19, coronavirus, niaid, remdesivier

The US National Institute of Allergy and Infectious Diseases (NAID) has announced that it is enrolling COVID-19 patients in hospital …

NICE gives thumbs-up to Roche’s Kadcyla in HER2+ breast cancer sub-population

May 7, 2020
Sales and Marketing Cancer, Kadcyla, NHS, NICE, Roche, UK, breast cancer

NICE has revealed that it has recommended the NHS use of Roche’s Kadcyla (trastuzumab emtansine) for HER2+ breast cancer in …

coronavirus_sars-cov-2

Black people are four times more likely to die from COVID-19 than white in England and Wales, ONS report shows

May 7, 2020
Business Services COVID-19, coronavirus

A recent report from the Office of National Statistics has shown that black people in England and Wales are four …

The Gateway to Local Adoption Series

Latest content